Dan Ouchi

2.0k total citations · 1 hit paper
50 papers, 781 citations indexed

About

Dan Ouchi is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Dan Ouchi has authored 50 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 17 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Dan Ouchi's work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (9 papers) and COVID-19 Clinical Research Studies (7 papers). Dan Ouchi is often cited by papers focused on HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (9 papers) and COVID-19 Clinical Research Studies (7 papers). Dan Ouchi collaborates with scholars based in Spain, United States and United Kingdom. Dan Ouchi's co-authors include Bonaventura Clotet, Javier Martínez‐Picado, María C. Puertas, Rosa Morros, Maria Giner‐Soriano, Bàrbara Baró, Camila González-Beiras, Julià Blanco, Quique Bassat and Marc Corbacho‐Monné and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Dan Ouchi

45 papers receiving 772 citations

Hit Papers

Transmission of COVID-19 in 282 clusters in Catalonia, Sp... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Ouchi Spain 15 425 342 156 149 88 50 781
Jorge Villacian Singapore 14 495 1.2× 286 0.8× 112 0.7× 210 1.4× 100 1.1× 21 800
Cuiling Xu United States 19 417 1.0× 326 1.0× 201 1.3× 560 3.8× 122 1.4× 52 995
Casper Rokx Netherlands 14 615 1.4× 301 0.9× 78 0.5× 127 0.9× 22 0.3× 72 799
Gemma Moncunill Spain 21 364 0.9× 160 0.5× 328 2.1× 107 0.7× 32 0.4× 70 1.0k
Giorgio Bozzi Italy 15 340 0.8× 201 0.6× 24 0.2× 141 0.9× 40 0.5× 40 613
David M. Tehrani United States 13 217 0.5× 582 1.7× 404 2.6× 235 1.6× 13 0.1× 38 1.2k
Santiago Ávila‐Ríos Mexico 19 623 1.5× 562 1.6× 144 0.9× 265 1.8× 10 0.1× 98 1.0k
Gilles Darcis Belgium 18 584 1.4× 655 1.9× 203 1.3× 220 1.5× 18 0.2× 70 1.1k
Maria Franca Pirillo Italy 19 933 2.2× 539 1.6× 127 0.8× 378 2.5× 24 0.3× 58 1.3k
Marie‐Luce Delforge Belgium 18 563 1.3× 155 0.5× 49 0.3× 582 3.9× 71 0.8× 48 999

Countries citing papers authored by Dan Ouchi

Since Specialization
Citations

This map shows the geographic impact of Dan Ouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Ouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Ouchi more than expected).

Fields of papers citing papers by Dan Ouchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Ouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Ouchi. The network helps show where Dan Ouchi may publish in the future.

Co-authorship network of co-authors of Dan Ouchi

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Ouchi. A scholar is included among the top collaborators of Dan Ouchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Ouchi. Dan Ouchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moragas, Ana, et al.. (2025). Urinary tract infections in women in Catalonia, Spain: a population-based observational cohort study in primary care. Frontiers in Pharmacology. 16. 1593910–1593910.
3.
Alemany, Andrea, Pere Millat-Martínez, Dan Ouchi, et al.. (2024). Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. Frontiers in Immunology. 15. 1501872–1501872.
4.
Ouchi, Dan, et al.. (2023). Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia. Diabetes Research and Clinical Practice. 202. 110777–110777. 2 indexed citations
5.
Ouchi, Dan, et al.. (2023). Impact of Second-Line Combination Treatment for Type 2 Diabetes Mellitus on Disease Control: A Population-Based Cohort Study. Drugs - Real World Outcomes. 10(3). 447–457. 1 indexed citations
6.
Llor, Carl, Ana Moragas, Dan Ouchi, et al.. (2022). Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial. Family Practice. 40(2). 407–413. 6 indexed citations
7.
Ouchi, Dan, et al.. (2022). Automatic Estimation of the Most Likely Drug Combination in Electronic Health Records Using the Smooth Algorithm: Development and Validation Study. JMIR Medical Informatics. 10(11). e37976–e37976. 3 indexed citations
8.
Giner‐Soriano, Maria, et al.. (2022). Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records. JMIR Public Health and Surveillance. 8(11). e36712–e36712. 6 indexed citations
9.
González-Beiras, Camila, Georgia S. Guldan, Ryan Moseley, et al.. (2022). Ficus septica exudate, a traditional medicine used in Papua New Guinea for treating infected cutaneous ulcers: in vitro evaluation and clinical efficacy assessment by cluster randomised trial. Phytomedicine. 99. 154026–154026. 8 indexed citations
10.
Moragas, Ana, et al.. (2022). Diagnostic and Therapeutic Management of Urinary Tract Infections in Catalonia, Spain: Protocol for an Observational Cohort Study. JMIR Research Protocols. 12. e44244–e44244. 4 indexed citations
11.
Kilpeläinen, Athina, Dan Ouchi, Ruth Peña, et al.. (2022). Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors. Frontiers in Immunology. 13. 815041–815041. 1 indexed citations
13.
Ruiz, Alba, Dan Ouchi, Beatriz Mothe, et al.. (2019). Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells. Frontiers in Immunology. 9. 3162–3162. 13 indexed citations
15.
Martínez‐Picado, Javier, Paul J. McLaren, Itziar Erkizia, et al.. (2016). Identification of Siglec-1 null individuals infected with HIV-1. Nature Communications. 7(1). 12412–12412. 23 indexed citations
16.
Pino, María, Itziar Erkizia, Susana Benet, et al.. (2015). HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology. 12(1). 37–37. 70 indexed citations
17.
Coll, J, José Moltó, Jaume Boix, et al.. (2015). Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers. AIDS. 29(16). 2149–2154. 14 indexed citations
18.
Massanella, Marta, Jorge Carrillo, Marta Curriu, et al.. (2015). Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery. Journal of Translational Medicine. 13(1). 230–230. 26 indexed citations
19.
Massanella, Marta, Dan Ouchi, Sílvia Marfil, et al.. (2014). Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals. PLoS ONE. 9(12). e114142–e114142. 18 indexed citations
20.
Puertas, María C., Marta Massanella, Josep M. Llibre, et al.. (2013). Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection. AIDS. 28(3). 325–334. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026